Finance

Lists
ELTX:NASDAQ
Elicio Therapeutics Inc
US$1,89
+1,34%
(+0,025) 1D
US$1,95
+3,17% (+0,060)
Pre-market
Closed: 18 ກ.ຍ., 16 ໂມງ 0 ນາທີ 02 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ELTX...
Open
US$1,86
High
US$2,00
Low
US$1,86
Mkt. cap
໔໙,໕໔ ລ້ານ
Avg. vol.
໓໐໗,໕໓ ພັນ
Volume
໒໙,໐໐
52-wk high
US$16,00
52-wk low
US$1,72
EPS
US$-2,18
Beta
໑,໒໙
Shares outstanding
໒໖,໒໘ ລ້ານ
No. of employees
໓໓
Open
US$1,86
High
US$2,00
Low
US$1,86
Mkt. cap
໔໙,໕໔ ລ້ານ
Avg. vol.
໓໐໗,໕໓ ພັນ
Volume
໒໙,໐໐
52-wk high
US$16,00
52-wk low
US$1,72
EPS
US$-2,18
Beta
໑,໒໙
Shares outstanding
໒໖,໒໘ ລ້ານ
No. of employees
໓໓
News stories
From web sources and news partners
About Elicio Therapeutics Inc
CEO-
Employees33
Founded2011
Headquartersບອສຕັນ, ມາຊາຊູເຊັດ, ສະຫະລັດ
SectorBiotechnology
Websiteelicio.com
Analyst ratings
Based on 2 analysts giving stock ratings to ELTX in the past 3 months
Buy
Buy
1
Hold
1
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ELTX in the last 3 months.
Highest
Current US$1,89
US$23,00 (+1.116,93%)
Average
US$23,00 (+1.116,93%)
Lowest
US$23,00 (+1.116,93%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert Burns
H.C. Wainwright
Buy
Reiterated
US$23,00
+1.116,9%
08/21/2026
Boris Peaker
JonesTrading
Hold
Reiterated
-
-
08/17/2026
Kevin DeGeeter
Ladenburg Thalmann & Co.
Buy
Initiated
US$12,00
+534,9%
06/18/2026
Mayank Mamtani
B. Riley Securities
Buy
Initiated
US$27,00
+1.328,6%
06/10/2026
Aydin Huseynov
Ladenburg Thalmann & Co.
Buy
Initiated
US$20,00
+958,2%
04/15/2026
Soumit Roy
JonesTrading
Buy
Maintained
US$18,00
+852,4%
04/06/2026
Michael King
Rodman & Renshaw
Buy
Initiated
US$17,00
+799,5%
03/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5,04 ລ້ານ
5,08 ລ້ານ
6,76 ລ້ານ
6,81 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,01 ລ້ານ
3,76 ລ້ານ
3,84 ລ້ານ
3,62 ລ້ານ
Operating expense
8,04 ລ້ານ
8,84 ລ້ານ
10,60 ລ້ານ
10,43 ລ້ານ
Total operating expenses
8,04 ລ້ານ
8,84 ລ້ານ
10,60 ລ້ານ
10,43 ລ້ານ
Operating income
-8,04 ລ້ານ
-8,84 ລ້ານ
-10,60 ລ້ານ
-10,43 ລ້ານ
Other non operating income
-1,81 ລ້ານ
1,26 ລ້ານ
-984,00 ພັນ
2,48 ລ້ານ
EBT including unusual items
-10,08 ລ້ານ
-7,72 ລ້ານ
-11,82 ລ້ານ
-8,22 ລ້ານ
EBT excluding unusual items
-10,08 ລ້ານ
-7,72 ລ້ານ
-11,82 ລ້ານ
-8,22 ລ້ານ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-10,08 ລ້ານ
-7,72 ລ້ານ
-11,82 ລ້ານ
-8,22 ລ້ານ
Net profit margin
-
-
-
-
Earnings per share
-0,60
-0,49
-0,65
-0,43
Interest and investment income
199,00 ພັນ
199,00 ພັນ
157,00 ພັນ
138,00 ພັນ
Interest expense
-426,00 ພັນ
-337,00 ພັນ
-407,00 ພັນ
-410,00 ພັນ
Net interest expenses
-227,00 ພັນ
-138,00 ພັນ
-250,00 ພັນ
-272,00 ພັນ
Depreciation and amortization charges
-
-
-
-
EBITDA
-8,00 ລ້ານ
-8,79 ລ້ານ
-10,56 ລ້ານ
-10,39 ລ້ານ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
ແອັບຂອງ Google